Cargando…
An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries
BACKGROUND: The Canadian government has committed to developing a national strategy for drugs for rare diseases starting in 2022. Considering this announcement, we conducted a comparative analysis to examine patient access to therapies for rare disease in Canada relative to Europe and the U.S. METHO...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895096/ https://www.ncbi.nlm.nih.gov/pubmed/35246200 http://dx.doi.org/10.1186/s13023-022-02260-6 |